The Multiple Sclerosis Care Unit

Treatment of multiple sclerosis (MS) has become increasingly multifaceted and comprises not only a variety of disease-modifying drugs with different mechanism of action but also a wide range of symptomatic therapies. Today, it is not possible for the family physician or even many general neurologists to master the current treatment algorithm, and this calls for the establishment of multidisciplinary MS Care Units. The core of the MS Care Unit would, in addition to MS neurologists and nurses, typically comprise neuropsychologists, clinical psychologists, physiotherapists, occupational therapists and secretaries, and will work together with a group of different specialists on formalized diagnostic workup procedures, protocols for initiation and follow-up of disease-modifying therapies. It is obvious that the terms of performance of different MS Care Units will vary across regions and need to be balanced with clinical practice according to local conditions. Although the main objective for establishment of MS Care Units will be to offer the single MS patient seamless and correct management of the disease to increase patient satisfaction and quality of life, it may even be cost-effective for the society by maintaining the working ability and reducing the costs of home help and custodial care by keeping people with MS resourceful.

[1]  Patrick Vermersch,et al.  The patient's perspective: How to create awareness for improving access to care and treatment of MS patients? , 2016, Multiple sclerosis.

[2]  V. Martinelli,et al.  Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres , 2017, European journal of neurology.

[3]  O. Ciccarelli,et al.  All relapsing multiple sclerosis patients should be managed at a specialist clinic – YES , 2016, Multiple sclerosis.

[4]  D. Mohr,et al.  Effects of Treatment for Depression on Fatigue in Multiple Sclerosis , 2003, Psychosomatic medicine.

[5]  Pierre Grammond,et al.  Towards personalized therapy for multiple sclerosis: prediction of individual treatment response , 2017, Brain : a journal of neurology.

[6]  D. Mazevet,et al.  Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study , 2015, Multiple sclerosis journal - experimental, translational and clinical.

[7]  C. Walsh,et al.  Impact of stroke units on mortality: a Bayesian analysis , 2010, European journal of neurology.

[8]  L. von Koch,et al.  Use of health care services and satisfaction with care in people with multiple sclerosis in Stockholm County: A population-based study , 2008, Multiple sclerosis.

[9]  G. Comi,et al.  Evolving concepts in the treatment of relapsing multiple sclerosis , 2017, The Lancet.

[10]  A. Langer-Gould The pill times 2 , 2014, Neurology.

[11]  O. Kantarci,et al.  Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – YES , 2016, Multiple sclerosis.

[12]  H. Mitsumoto,et al.  Subcommittee of the American Academy of Neurology Evidence-based Review) : Report of the Quality Standards Management, and Cognitive/behavioral Impairment (an Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Practice Parameter Update: the Care of the Patient With , 2022 .

[13]  P. Sørensen Safety concerns and risk management of multiple sclerosis therapies. , 2017 .

[14]  G. Fenu,et al.  What do multiple sclerosis patients and their caregivers perceive as unmet needs? , 2013, BMC Neurology.

[15]  J. Pionke,et al.  Barriers to the Accessibility and Continuity of Health-Care Services in People with Multiple Sclerosis: A Literature Review. , 2017, International journal of MS care.

[16]  G. Comi,et al.  Survey of diagnostic and treatment practices for multiple sclerosis in Europe , 2017, European journal of neurology.

[17]  O. Hardiman,et al.  Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000 , 2003, Journal of neurology, neurosurgery, and psychiatry.

[18]  P. Clavelou Can we optimize our teams? Multidisciplinary care for multiple sclerosis , 2013, Expert review of neurotherapeutics.

[19]  Margaret Anderson,et al.  On the path to a science of patient input , 2016, Science Translational Medicine.

[20]  Xavier Montalban,et al.  Treatment decisions in multiple sclerosis — insights from real-world observational studies , 2017, Nature Reviews Neurology.

[21]  Gavin Giovannoni,et al.  The importance of a multi-disciplinary perspective and patient activation programmes in MS management , 2016, Multiple sclerosis.

[22]  A. Thompson,et al.  Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper , 2016, Multiple sclerosis.

[23]  L. Widén Holmqvist,et al.  Variations in functioning and disability in multiple sclerosis , 2008, Journal of Neurology.

[24]  C. Lubetzki,et al.  Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – NO , 2016, Multiple Sclerosis.

[25]  A. Lo,et al.  Treatment of progressive multiple sclerosis: what works, what does not, and what is needed , 2015, The Lancet Neurology.

[26]  O. Ciccarelli,et al.  Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions , 2010, The Lancet Neurology.

[27]  Jeffrey A. Cohen,et al.  The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review , 2015, Multiple sclerosis.

[28]  Peter Langhorne,et al.  Organised inpatient (stroke unit) care for stroke. , 2007, The Cochrane database of systematic reviews.

[29]  O. Hardiman,et al.  A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[30]  M. Pollack,et al.  Comprehensive Stroke Units: A Review of Comparative Evidence and Experience , 2013, International journal of stroke : official journal of the International Stroke Society.

[31]  A. Thompson,et al.  Exercise in patients with multiple sclerosis , 2017, The Lancet Neurology.

[32]  P. Soelberg Sørensen Safety concerns and risk management of multiple sclerosis therapies , 2017, Acta neurologica Scandinavica.

[33]  M. Hutchinson,et al.  Unmet needs of multiple sclerosis patients in the community. , 2015, Multiple sclerosis and related disorders.